Semaglutide has emerged as a significant medication in both diabetes management and, increasingly, weight loss. Originally developed to treat type 2 diabetes, its weight loss benefits have propelled it into the spotlight, making it a topic of considerable interest and research.
Understanding Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the effects of the natural hormone GLP-1, which is released in response to food intake. This hormone plays a crucial role in managing blood glucose levels by increasing insulin production, slowing down digestion, and reducing appetite.
How Semaglutide Works
Semaglutide influences the brain’s appetite control centers, reducing hunger and increasing feelings of fullness. This mechanism helps individuals consume fewer calories, leading to weight loss. It also slows food moving through the intestines, telling your brain it’s not hungry.
Semaglutide for Weight Loss: The Science and Studies
Clinical trials have demonstrated the effectiveness of semaglutide in promoting weight loss. Participants in these trials have experienced substantial weight reduction, often averaging 15% or more of their body weight.
STEP Trials: A Closer Look
The STEP (Semaglutide Treatment Effect in People with obesity) trials have been instrumental in evaluating the efficacy of semaglutide for weight management. These trials have explored different dosages and populations, providing valuable insights into the drug's potential.
Read also: CPAP Machine Benefits
- STEP UP Diabetes Trial: This trial tracked 512 adults with obesity and Type 2 diabetes. Participants were assigned to three groups: 307 took 7.2 mg of semaglutide weekly, 103 took 2.4 mg weekly, and 102 took a placebo. After 72 weeks, those taking 2.4 mg lost an average of 10.4% of their starting weight, compared to 3.9% in the placebo group. Notably, those on the higher 7.2 mg dose lost even more weight, averaging 13.2%.
- STEP UP Obesity Trial: This trial enrolled people living with obesity but without Type 2 diabetes.
- Further STEP Trial Results:
- Patients treated with semaglutide 2.4 mg achieved significant weight loss compared to placebo or liraglutide.
- Approximately 86.4% of patients treated with semaglutide 2.4 mg experienced a weight loss of 5% or more.
- A study over 68 weeks showed a weight loss of -16.0% with semaglutide compared to lifestyle interventions alone.
- Another study showed that 86.6% of patients treated with semaglutide achieved a weight loss of 5% or more.
- Continued semaglutide treatment resulted in a weight loss of -17.4%, while discontinuation led to -15.2%.
- Patients receiving semaglutide experienced a weight loss of -15.8%, and 87.2% achieved a weight loss of 5% or more.
Higher Doses, Greater Weight Loss
A clinical trial led by a UT Southwestern Medical Center researcher showed that tripling the standard dose of semaglutide led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects. In the phase 3b STEP UP Diabetes trial, those taking the higher dose (7.2 mg) lost even more weight, 13.2% on average.
Beyond Weight Loss: Additional Health Benefits
While weight loss is a primary focus, semaglutide offers several other health benefits, particularly for individuals with type 2 diabetes and cardiovascular disease.
Glycemic Control
Semaglutide was initially approved for the treatment of type 2 diabetes in 2017. Clinical trials found that it lowered the diabetes management marker hemoglobin A1C, on average, by up to 2 percentage points. People taking semaglutide also were more likely to achieve an A1C treatment goal of less than 7% compared with using other medicines.
Cardiovascular Risk Reduction
Studies have found that semaglutide reduces the risk of major cardiovascular events, including heart attack and stroke, in adults with overweight or obesity who have known cardiovascular disease, both with and without diabetes. A large clinical trial in people with diabetes found semaglutide can reduce the risk of major cardiovascular events or death by 26% compared with placebo. It may also protect the kidneys from damage caused by high blood sugar levels, which can lead to chronic kidney disease and kidney failure.
Heart Failure Improvement
Semaglutide has also been studied in individuals with certain types of obesity-related heart failure, both with and without diabetes. Studies suggest that semaglutide may help improve heart failure-related symptoms, such as tiredness, shortness of breath, and swelling.
Read also: Healthy food access with Highmark Wholecare explained.
Potential Side Effects and Risks
Like any medication, semaglutide can cause side effects. It’s essential to be aware of these potential issues and discuss them with your healthcare provider.
Common Side Effects
Some common side effects of Semaglutide include nausea, diarrhea, constipation, and abdominal pain. These side effects are typically mild and improve over time. In the STEP trials, the most common side effect was gastrointestinal symptoms, which affected about half of the patients on either dose and about a quarter of patients on the placebo. These side effects were typically present while participants were gradually increasing their dose in the first few weeks of the trial and tended to improve thereafter. The only side effect experienced by more of those on the higher semaglutide dose was dysaesthesia, which alters touch sensation.
More Serious Risks
More severe risks, although less common, can include pancreatitis and kidney problems, which necessitate immediate medical attention. Semaglutide is not recommended for people with type 1 diabetes, diabetic ketoacidosis, or a history of pancreatitis or a certain type of thyroid cancer.
Long-Term Effects
As of now, the long-term effects of semaglutide use for weight loss are not well-known.
The Importance of Medical Supervision
Using semaglutide for weight loss under the guidance of healthcare professionals is crucial for ensuring both safety and effectiveness. Medical supervision allows for the careful tailoring of dosage and monitoring of progress, which is essential for achieving the desired outcomes.
Read also: Risks of Salad Dieting
Personalized Treatment Plans
Healthcare providers are equipped to make informed decisions about the appropriate dosage and to adjust treatment plans as needed. This personalized approach helps to maximize the benefits of semaglutide while minimizing potential risks.
Monitoring and Adjustments
By ensuring that patients are closely monitored, medical professionals can help prevent complications and enhance the overall success of the treatment. This oversight helps mitigate risks and ensures that the benefits of semaglutide are maximized while minimizing potential harm.
Semaglutide vs. Other Weight Loss Options
In the realm of weight loss medications, semaglutide stands out due to its unique benefits and considerations. Unlike some other options, semaglutide offers sustained weight loss and improved metabolic health, making it an attractive choice for many.
Non-Surgical Alternative
Semaglutide fits into the broader landscape of weight loss solutions by offering a non-surgical option that can be tailored to individual needs. Its ability to promote significant weight loss without the need for invasive procedures makes it a compelling choice for those seeking an alternative to traditional methods.
Other Approved Medications
It's important to note other approved medications for chronic weight management, excluding orlistat and liraglutide 3 mg. The choice of medication should be based upon the side effects, precautions, and contraindications of a medication.
Preparing for Semaglutide Treatment
Before starting semaglutide treatment, potential users should be aware of several key considerations.
Lifestyle Modifications
Dietary adjustments and lifestyle changes are often necessary to maximize the effectiveness of the medication. By incorporating healthy eating habits and regular physical activity, patients can enhance their weight loss results and improve overall well-being. Lifestyle interventions were consistent with the STEP 1 trials, including increased physical activity.
Realistic Expectations
Setting realistic expectations and goals is another important aspect of preparing for semaglutide treatment. Understanding that weight loss is a gradual process can help individuals stay motivated and committed to their journey.
Practical Considerations
Administration
Semaglutide is typically taken as a once-weekly injection. You use a small needle to inject the medication into fatty tissue - usually in your belly, thighs, arms, or upper buttocks. Semaglutide is administered subcutaneously without regard to meals. The bioavailability of semaglutide is 89% when injected subcutaneously. Administration sites include the abdomen, thigh, and upper arm.
Cost and Availability
Currently, there are two potential barriers to starting or continuing semaglutide: cost and availability. The average retail cost of a 28-day supply of semaglutide is over $1,000. Your cost will vary depending on your insurance coverage, dosage, and the specific brand prescribed. Discounts, coupons, and assistance programs may be available.
Dosage
Dosages are usually escalated over time to protect from natural degradation by dipeptidyl-peptidase 4 (DPP-4). A typical titration schedule includes gradual increases to doses of 0.5 mg, 1 mg, and 1.7 mg, and the maintenance dose of 2.4 mg. There is typically a 4-week delay in dose escalation to allow the body to adjust.
tags: #semaglutide #weight #loss #benefits